The ‘Steroid Olympics’ Brought to You By Big Tech - The Story

The traditional boundaries of human physical performance are constantly being pushed, not just by training, but increasingly by technology and biochemistry. This convergence forces a re-evaluation of what constitutes fair competition and what the future of human achievement might look like, a question now being concretized in a new sporting venture. In a recent episode, TechStuff delves into the nascent Enhanced Games, colloquially dubbed the “Steroid Olympics.” Host Oz Kasauskas discusses with Chris Gayomali, host of the *SuperHuman* podcast, the conceptual underpinnings and practical implications of this competition, where performance-enhancing drugs are not only permitted but encouraged. The discussion unpacks how this model seeks to address the financial precarity of athletes impacted by age-related decline, drawing parallels to the high-stakes, technology-driven environment of Formula One. Key to understanding its immediate legitimacy are the notable financial endorsements from figures like Peter Thiel and Donald Trump Jr., signaling a significant, if controversial, entry into the athletic landscape. The interview explores how the Enhanced Games positions itself as a disruptive force, challenging the established ethical frameworks of traditional sports. Gayomali emphasizes the financial motivations for athletes, highlighting how a permissive stance on enhancement could extend careers and earning potential. The involvement of such prominent investors suggests a serious bid for market share, betting on an audience intrigued by the spectacle of unconstrained human potential. For software, AI, and product builders, this discussion offers a lens into the intersection of innovation, ethics, and market disruption. Consider how established industries might be similarly challenged by new paradigms that leverage evolving technological or biological capabilities. Examining the strategic calculus behind the Enhanced Games’ funding and marketing could provide insights into how to position a disruptive product or service in a highly regulated or ethically charged domain.